arrow
M

María José Picón César

ciber - centro de investigacion biomedica en red
H指数:18
被引数:962

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism

醛固酮受体拮抗剂术前肾上腺切除术在原发性醛固酮增多症中的应用

2025-11-010
OAAI
A Real-World Study Comparing Advanced Hybrid Closed-Loop Systems During Pregnancy in Women with Type 1 Diabetes

一项真实世界研究,比较妊娠期1型糖尿病女性使用先进混合闭环系统的效果

2025-09-260
PRE
External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy

S-GRAS评分在预测肾上腺皮质癌患者复发中的外部验证:对辅助米托坦治疗的启示

2025-08-140
PRE
Efficacy and safety of medical treatment of primary aldosteronism: a real-world data study in Spain

原发性醛固酮增多症药物治疗的有效性与安全性:一项西班牙真实世界数据研究

2025-07-310
OAAI
Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO

原发性醛固酮增多症对钙磷稳态的影响。SPAIN-ALDO研究的结果

2025-04-190
PRE
Does Adjuvant Mitotane Impact Cure Rates in Adrenocortical Carcinoma? Insights From the ICARO-GETTHI/SEEN Registry
2025-02-140
OA
Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study

妊娠前使用最小780G与最小640G的妊娠结局: 一项多中心队列研究的结果

2024-12-041
PRE
Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study
2024-11-180
OA
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting (vol 47, pg 216, 2024)

多中心前瞻性评估两种先进混合闭环系统在真实世界环境中的血糖控制和患者报告结局(卷47,页216,2024)

2024-09-120
PRE
Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry
2024-07-051
PRE
A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting Response
2024-04-190
OA
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism
2024-03-012
OAAI
Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry
2024-01-163
PRE
Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

肾上腺静脉取样是否总是需要区分单侧和双侧原发性醛固酮增多症?西班牙-奥尔多登记册的教训

2023-11-275
OA